Decreases in circulating ANGPTL3 /8 concentrations following retatrutide treatment parallel reductions in serum lipids

Documents similaires

• Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study
  par: Chisom Kanu, et autres
  Publié: (2025)
• Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction
  par: Sam F. Kennedy, et autres
  Publié: (2025)
• Association between patient‐reported eating behaviours and weight change: Secondary analyses of a randomized, double‐blind trial comparing retatrutide and placebo in people with obesity or overweight
  par: Chisom Kanu, et autres
  Publié: (2025)
• A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy
  par: Filip K. Knop, et autres
  Publié: (2024)
• Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
  par: Jun Wang, et autres
  Publié: (2025)